Presbyopia treatments

US10610518B2 · kind B2 · utility

Assignee

• Allergan, Inc. · US

Inventors

• Michael R. Robinson · Irvine, US
• Mohammed I. Dibas · Laguna Niguel, US
• Jaya Giyanani · Irvine, US
• Anuradha V. Gore · Aliso Viejo, US
• Sungwook Lee · Orange, US
• Haixia Liu · Shanghai, CN
• Aileen Morgan · Rancho Santa Margarita, US
• Jihao Zhou · Rancho Santa Margarita, US

Key dates

• Filing date: Apr 24, 2019
• Grant date: Apr 7, 2020
• Expiry date: Apr 24, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/186
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.